Harnessing the Power of the Innate Immunity to Fight Solid Tumor

Time: 11:45 am
day: Conference Day One - Track A

Details:

  • Developing off-the-shelf allogeneic healthy donor-derived γδ T cell therapy for solid tumor
  • Polyclonal, natural composition of γδ T cell subsets, leveraging the non-redundant functions of diverse subsets
  • Armed and engineered dual CAR targets tumor and immunesupporessive stroma in the TME to optimize anti-tumor potency
  • Gene editing to overcome immune suppression in the solid tumor TME

Speakers:

Haiyan Jiang
Haiyan Jiang